News from NORD

Join the National Organization for Rare Disorders and the University of Massachusetts for Two Upcoming CME-Accredited Events


 

Do you currently treat patients with rare diseases? Do you suspect that you might have a patient with an undiagnosed rare disease? The National Organization for Rare Disorders (NORD) and the University of Massachusetts Medical School have designed two events for you and your colleagues to learn more about rare diseases and the available diagnostic tools.

An interactive half-day symposium on diagnostic hurdles, tools, and resources is planned for Sunday, October 16, 2017, at the Marriott Wardman Park Hotel in Washington DC. This event, “Finding a Zebra Among Many Horses,” will focus on challenges and resources related to rare disease diagnosis.

On the following two days, Oct. 16 and 17, NORD’s Rare Diseases and Orphan Products Breakthrough Summit will take place at the same location and is also CME-accredited. Topics to be covered will include:

  • Assuring Patient Access: Future Outlook for Patient Assistance Programs
  • The Challenge of Health Care Costs and Treatment Prices
  • An Evergreen and Sustainable Approach to Orphan Drugs
  • Next-Generation Treatments and Advancing Clinical Trials

The NORD Breakthrough Summit attracts approximately 600 participants from rare disease stakeholder groups, including clinicians, researchers, patient advocates, and government partners from the NIH and FDA.

Online registration is available now for either or both events.

Recommended Reading

NORD Welcomes All Things Kabuki as New Member
MDedge Hematology and Oncology
Alpha-1 Foundation Announces Funding Opportunities
MDedge Hematology and Oncology
cureCADASIL Announces Publication of Study Results
MDedge Hematology and Oncology
Hyper IgM Foundation Publishes Blog
MDedge Hematology and Oncology
MSA Coalition Plans Patient/Family Conference
MDedge Hematology and Oncology
Neuroendocrine Tumor Research Foundation Issues Request for Proposals
MDedge Hematology and Oncology
Spinal CSF Leak Foundation and Cedars-Sinai Plan Intracranial Hypotension Symposium
MDedge Hematology and Oncology
Vestibular Disorders Association Celebrates Balance Awareness Week
MDedge Hematology and Oncology
VIDEO: Triple therapy study and new recommendations provide guidance on CAPS
MDedge Hematology and Oncology
Eribulin superior to dacarbazine in advanced liposarcoma
MDedge Hematology and Oncology